Stockreport

Biodexa Announces Pricing of $10 Million Public Offering

Biodexa Pharmaceuticals plc - American Depositary Shares  (BDRX) 
PDF December 18, 2025 Biodexa Announces Pricing of $10 Million Public Offering Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX) (“Biodexa” or the “Company”), a clinical stage [Read more]